Skip to main content

Table 1 Information on the hiPSC lines. 

From: Human iPSC-derived astrocytes transplanted into the mouse brain undergo morphological changes in response to amyloid-β plaques

hiPSC line hiPSC name Ethnicity Gender Age of onset Age at skin biopsy Disease status (CDR at biopsy) APOE genotype Genetic modification
1 TCW1E33-1F1 Caucasian F 64 72 AD (2) E4/E4 E3/E3
2 TCW1E44-2C2 Caucasian F 64 72 AD (2) E4/E4 E4/E4
3 TCW2E33-3D11 Caucasian M 77 80 AD (0.5) E4/E4 E3/E3
4 TCW2E44-4B12 Caucasian M 77 80 AD (0.5) E4/E4 E4/E4
5 TCW2E33-2E3 Caucasian M 77 80 AD (0.5) E4/E4 E3/E3
6 TCW2E44-4B1 Caucasian M 77 80 AD (0.5) E4/E4 E4/E4
7 TCW3E33-H-2 Caucasian M 80 83 AD (0.5) E4/E4 E3/E3
8 TCW3E44-F-2 Caucasian M 80 83 AD (0.5) E4/E4 E4/E4
  1. The table shows hiPSC name, patient ethnicity, gender, age of AD onset, age at skin biopsy, disease status (CDR at biopsy), original APOE genotype and genetic modification. F female, M male, AD Alzheimer’s disease, APOE apolipoprotein, CDR clinical dementia rating, hiPSC human induced pluripotent stem cells. These cells were previously generated and characterized by [29]